PPH - VanEck Pharmaceutical ETF Analysis | Stock Taper
Logo

PPH

VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF VanEck
$111.70 2.01% (+2.20)

Managing Company VanEck
Asset Under Management $1.31B
Inception Date Dec 20, 2011
Expense Ratio 0.36%
52w High $112.58
52w Low $77.67
Volume 57,555
Avg Volume 430,905
Asset Class Equity

About VanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

SECTOR HOLDINGS

Healthcare Healthcare
100.00%

ASSET ALLOCATION BY REGION

United States flag United States
61.19%
United Kingdom flag United Kingdom
12.46%
Switzerland flag Switzerland
11.42%
Denmark flag Denmark
4.54%
France flag France
4.01%
Japan flag Japan
2.90%
Israel flag Israel
2.63%
Ireland flag Ireland
0.77%
Canada flag Canada
0.09%